The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
MedWatch The FDA Safety Information and Adverse Event Reporting Program
Audience: Obstetricians/Gynecologists and other healthcare professionals
The following is new safety information about Mifeprex (mifepristone):
[April 17, 2002 - Letter - Danco][April 17, 2002 - Q&A - FDA]
Page Last Updated: 08/20/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English